ProPhase Labs, Inc. (PRPH) Financials
PRPH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 91.7 million | 35.3 million |
| 2023-06-30 | 91.1 million | 31.8 million |
| 2023-03-31 | 95.4 million | 35.4 million |
| 2022-12-31 | 87.6 million | 24.0 million |
PRPH Free Cash Flow and Stock based compensation
No data available :(
PRPH Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-09-30 | -5.1 million |
| 2023-06-30 | -3.4 million |
| 2023-03-31 | 550000 |
| 2022-12-31 | -2.4 million |
PRPH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 3.3 million | - | 11.6 million |
| 2023-06-30 | 9.1 million | 9.6 million | 6.8 million |
| 2023-03-31 | 15.6 million | 9.6 million | 4.5 million |
| 2022-12-31 | 17.4 million | - | 4.6 million |
PRPH Shares Outstanding
PRPH Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 668000 | 428000 | 8.2 million | - |
| 2023-06-30 | 660000 | 572000 | 9.9 million | - |
| 2023-03-31 | 517000 | 144000 | 9.5 million | - |
| 2022-12-31 | 1.6 million | 478000 | 15.9 million | - |
PRPH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 8.4 million | 6.0 million |
| 2023-06-30 | 13.2 million | 6.8 million |
| 2023-03-31 | 19.3 million | 8.8 million |
| 2022-12-31 | 21.8 million | 10.5 million |
PRPH
Price: $4.67
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.63 USD
P/E Ratio: -8.25
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 65100
Ebitda: -2.3 millionMarket Capitalization: 122.7 million